Medidrop Pharma Private Limited
About Medidrop Pharma Private Limited
Data last updated:
Medidrop Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 January 2022.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2022PTC079355. Its GSTIN is 08AAPCM4053K1Z1 (Rajasthan). The company holds 12 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Kumar Gangwal and Sumangla Gangwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 73 – 251 Masarover Jaipur, Rajasthan, India – 302020.
As per the financials filed for FY 2025, the company reported a revenue of ₹292.83 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹1.28 Cr (net margin -0.4%) and EBITDA of -₹1.07 Cr (EBITDA margin -0.4%).
The company has about 31 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address73 – 251 Masarover Jaipur, Rajasthan, India – 302020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medidrop Pharma Private Limited
The main business activity of Medidrop Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medidrop Pharma Private Limited FY 2025 filings available
Medidrop Pharma Private Limited reported revenue of ₹292.83 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medidrop Pharma Private Limited
Revenue fell 2% in the latest year. EBITDA fell 111% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Medidrop Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.07 Cr | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.28 Cr | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Medidrop Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.4% | •••• | •••• | •••• |
| Net Profit Margin | -0.4% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medidrop Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Medidrop Pharma Private Limited
Medidrop Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kumar Gangwal | Director | 29 Jan 2022 | 4 Years 8 Months | Current |
| Sumangla Gangwal | Director | 29 Jan 2022 | 4 Years 8 Months | Current |
Peer Comparison of Medidrop Pharma Private Limited
Medidrop Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Magnet Labs Private Limited | ₹300.67 Cr (FY 2022) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
| Lazz Medico Private Limited | ₹300.3 Cr (FY 2025) | •••• | •••• | 40.0% | •••• | Kolkata, West Bengal, India |
| Missionpharma Logistics (India) Private Limited | ₹298.76 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Ahmedabad, Gujarat, India |
| Lifecare Pharma Private Limited | ₹294.25 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Chennai, Tamil Nadu, India |
| Teva Pharmaceutical and Chemical Industries India Private Limited | ₹293.98 Cr (FY 2025) | •••• | •••• | 142.0% | •••• | Mumbai, Maharashtra, India |
| Medidrop Pharma Private Limited this company | ₹292.83 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Jaipur, Rajasthan, India |
| Jaya Surgical and Pharma Private Limited | ₹292.53 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Hyderabad, Telangana, India |
| Saket Maternity and Nursing Home Private Limited | ₹289.13 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Uttar Pradesh, India |
| Balaxi Pharmaceuticals Limited Listed | ₹288.84 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Hyderabad, Telangana, India |
| D. C. Agencies Private Limited | ₹283.66 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| Impex Healthcare Private Limited | ₹283.06 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Medidrop Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medidrop Pharma Private Limited
Medidrop Pharma Private Limited is audited by CA Avinash Sinyal for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CA Avinash Sinyal | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Medidrop Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medidrop Pharma Private Limited
Medidrop Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medidrop Pharma Private Limited
Medidrop Pharma Private Limited has a workforce of 31 employees as of Mar 31, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medidrop Pharma Private Limited
Medidrop Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Raj Kumar Gangwal was appointed as Director on 29 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts for Medidrop Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medidrop Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medidrop Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medidrop Pharma Private Limited
Medidrop Pharma has 12 GST registrations: 12 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAPCM4053K1Z1 | Rajasthan | Active | 30 Mar 2022 |
| 37AAPCM4053K1Z0 | Andhra Pradesh | Active | 26 Mar 2022 |
| 22AAPCM4053K1ZB | Chattisgarh | Active | 01 Apr 2022 |
| 05AAPCM4053K1Z7 | Uttarakhand | Active | 05 Apr 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medidrop Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medidrop Pharma Private Limited
Medidrop Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 January 2022 (4+ years old) and is registered under CIN U51909RJ2022PTC079355.
Medidrop Pharma reported revenue of ₹292.83 Cr for FY 2025 (down 2% YoY).
Medidrop Pharma has 2 current directors:
- Raj Kumar Gangwal - Director
- Sumangla Gangwal - Director
Medidrop Pharma reported a net loss of ₹1.28 Cr (net margin -0.4%) and EBITDA of -₹1.07 Cr (EBITDA margin -0.4%) for FY 2025, as per its filed financial statements.
The GSTIN of Medidrop Pharma is 08AAPCM4053K1Z1, registered in Rajasthan. The company has 12 GST registrations in all, of which 12 are active. Other active GSTINs include 37AAPCM4053K1Z0 (Andhra Pradesh), 22AAPCM4053K1ZB (Chattisgarh), 05AAPCM4053K1Z7 (Uttarakhand).
The CIN (Corporate Identification Number) of Medidrop Pharma is U51909RJ2022PTC079355. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medidrop Pharma was incorporated on 29 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Medidrop Pharma by revenue are Magnet Labs Private Limited, Lazz Medico Private Limited, Missionpharma Logistics (India) Private Limited, Lifecare Pharma Private Limited, Teva Pharmaceutical and Chemical Industries India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Raj Kumar Gangwal was appointed as Director on 29 Jan 2022. Sumangla Gangwal was appointed as Director on 29 Jan 2022.
The registered office of Medidrop Pharma is at 73 – 251 Masarover Jaipur, Rajasthan, India – 302020.
Medidrop Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.